Clinical Trials Directory

Trials / Unknown

UnknownNCT03401216

StEnt Coverage and Neointimal Tissue Characterization After eXtra Long evErolimus - Eluting Stent imPlantation

StEnt Coverage and Neointimal Tissue Characterization After eXtra Long evErolimus - Eluting Stent imPlantation: Prospective sTudy Using optIcal cOhereNce Tomography

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Meshalkin Research Institute of Pathology of Circulation · Network
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the rate of SYNERGY 48 mm stent strut coverage and assess neointimal progression via OCT measurement in patients who underwent PCI.

Detailed description

Patients with stable, unstable angina and non-ST-elevation ACS will be included in this study. Patient will undergo coronary angiography for coronary anatomy assessment and estimation indications for PCI . After screening an OCT-guided PCI with extra long SYNERGY stent implantation will be provided in all patients. Patient will be divided into 2 groups of follow-up and will be followed within 3 and 6 month after procedure. Final clinical follow-up will be assessed at 12 month for all patients. At each follow-up visits the data regarding clinical events, coronary angiography and OCT-imaging will be collected.

Conditions

Interventions

TypeNameDescription
DEVICESYNERGY 48 mmMaterial: Platinum-Chromium alloy. Stent strut thickness: 0.0029-0.0032 inches. Polymer carrier composed of PLGA (poly(DL-lactide-co-glycolide)). Drug product: Everolimus, 1µg per 1 mm2. Stent diameters available: 2.25; 2.50; 2.75; 3.00; 3.50; 4.00 mm. Stent length: 48 mm. Nominal balloon pressure: 11 atm. (1117 kPa). Manufacturing company: Boston Scientific Corporation (USA)
PROCEDUREPCIStandard PCI procedure
PROCEDURE3 month OCT follow-upOptical coherence tomography imaging of target vessel within 3 month after PCI
PROCEDURE6 month OCT follow-upOptical coherence tomography imaging of target vessel within 5 month after PCI

Timeline

Start date
2017-03-20
Primary completion
2018-04-30
Completion
2019-04-30
First posted
2018-01-17
Last updated
2018-01-17

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT03401216. Inclusion in this directory is not an endorsement.